Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.00052
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Engineered AAV Vectors for Improved Central Nervous System Gene Delivery

Neurogenesis
Developmental NeuroscienceDevelopmental Biology
2015English

Immune Checkpoint Inhibitors and irAEs

Trends in Immunotherapy
2018English

4) Immune-Related Adverse Events in Endocrine Organs Induced by Immune Checkpoint Inhibitors

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
2019English

Immune Checkpoint Inhibitors for Metastatic Bladder Cancer

Cancer Treatment Reviews
MedicineOncologyRadiologyNuclear MedicineImaging
2018English

Review of Cancer Treatment With Immune Checkpoint Inhibitors

Wiener Klinische Wochenschrift
Medicine
2017English

Biomarkers for Immune Checkpoint Inhibitors: The Importance of Tumor Topography and the Challenges to Cytopathology

Cancer cytopathology
Cancer ResearchOncology
2017English

Hyperprogression and Immune Checkpoint Inhibitors: Hype or Progress?

Oncologist
Cancer ResearchMedicineOncology
2019English

Update on Immune Checkpoint Inhibitors in Gynecological Cancers

Journal of Gynecologic Oncology
MedicineGynecologyOncologyObstetrics
2017English

3) Immune Checkpoint Inhibitors for Gastrointestinal Tract Cancers

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy